Bjørn O Eriksen Selected Research

Type 2 Diabetes Mellitus (MODY)

12/2022	Molecular programs associated with glomerular hyperfiltration in early diabetic kidney disease.
1/2019	Correlation Between Baseline GFR and Subsequent Change in GFR in Norwegian Adults Without Diabetes and in Pima Indians.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Bjørn O Eriksen Research Topics

Disease

16	Cardiovascular Diseases (Cardiovascular Disease) 09/2023 - 12/2010
10	Kidney Diseases (Kidney Disease) 09/2023 - 12/2010
6	Albuminuria 12/2022 - 01/2007
4	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2018 - 01/2007
3	Renal Insufficiency (Renal Failure) 10/2022 - 01/2007
3	Ischemic Stroke 11/2018 - 07/2012
2	Hypertension (High Blood Pressure) 09/2023 - 01/2021
2	Proteinuria 01/2023 - 11/2020
2	Type 2 Diabetes Mellitus (MODY) 12/2022 - 01/2019
2	Chronic Renal Insufficiency 01/2021 - 01/2007
2	Diabetes Mellitus 01/2018 - 12/2010
1	Hyperglycemia 09/2023
1	Solitary Kidney 12/2022
1	Diabetic Nephropathies (Diabetic Nephropathy) 12/2022
1	Fibrosis (Cirrhosis) 01/2022
1	Colorectal Neoplasms (Colorectal Cancer) 01/2022
1	Inflammation (Inflammations) 08/2021
1	Humeral Fractures 01/2021
1	Myocardial Infarction 11/2018
1	Isolated Systolic Hypertension 02/2017
1	Left Ventricular Hypertrophy (Ventricular Hypertrophy, Left) 01/2017
1	Hypertrophy 01/2017
1	Overweight 05/2016
1	Hyperuricemia 01/2016
1	Neoplasms (Cancer) 07/2012
1	Hyperinsulinism (Hyperinsulinemia) 07/2011
1	Stroke (Strokes) 12/2010
1	Dyslipidemias (Dyslipidemia) 01/2007
1	Insulin Resistance 01/2007

Drug/Important Bio-Agent (IBA)

16	Iohexol (Omnipaque)FDA Link 09/2023 - 12/2010
8	CreatinineIBA 01/2023 - 01/2007
4	HDL CholesterolIBA 09/2023 - 01/2007
4	AlbuminsIBA 12/2022 - 01/2007
4	Cystatin CIBA 01/2021 - 12/2010
4	Glucose (Dextrose)FDA LinkGeneric 01/2018 - 01/2007
3	Biomarkers (Surrogate Marker)IBA 01/2021 - 01/2007
2	Triglycerides (Triacylglycerol)IBA 09/2023 - 01/2018
2	Proteins (Proteins, Gene)FDA Link 07/2022 - 11/2020
2	Uric Acid (Urate)IBA 05/2017 - 05/2016
2	AdiponectinIBA 01/2017 - 01/2016
1	HDL LipoproteinsIBA 09/2023
1	LigandsIBA 12/2022
1	Iothalamic Acid (Iotalamic Acid)FDA Link 12/2022
1	Tec protein-tyrosine kinaseIBA 12/2022
1	Orosomucoid (Seromucoid)IBA 12/2022
1	Endothelin-1 (Endothelin 1)IBA 12/2022
1	Tissue Inhibitor of Metalloproteinase-1IBA 01/2022
1	Matrix Metalloproteinase 2 (Gelatinase A)IBA 01/2022
1	Epidermal Growth Factor (EGF)IBA 01/2021
1	Edetic Acid (EDTA)FDA Link 01/2021
1	Syndecan-4IBA 11/2018
1	Syndecan-1 (Syndecan 1)IBA 11/2018
1	Antihypertensive Agents (Antihypertensives)IBA 02/2017
1	Hexosaminidases (Hexosaminidase)IBA 02/2016
1	Lipoproteins (Lipoprotein)IBA 01/2007
1	Insulin (Novolin)FDA Link 01/2007

Therapy/Procedure

2	Renal Replacement Therapy (Therapies, Renal Replacement) 10/2022 - 01/2021
1	Denervation 01/2021
1	Therapeutics 01/2021
1	Kidney Transplantation 01/2021
1	Conservative Treatment 01/2021